- Date de réalisation : 25 Septembre 2020
- Durée du programme : 32 min
- Classification Dewey : Maladies des poumons (hypertension artérielle pulmonaire, hypertension pulmonaire, maladie obstructive respiratoire chronique, maladies respiratoires, ouvrages généraux sur les maladies des bronches et des poumons)
Dans la même collectionDr Rodrigo Guabiraba - Precision cut lung slices: a novel versatile tool to examine host–pathogen ... Dr Guido Santos - Multi-level computational modeling as a tool to understand molecular mechanisms ... Prof. Mike Surette - The Good and the Bad of Commensal-Pathogen Interactions in the Airways Dr Raphaël Duivenvoorden - Trained Immunity as a novel therapeutic strategy Dr Aurélie Crabbé - Host metabolites modulate bacterial susceptibility to antibiotics Dr Mustapha Si-Tahar - Towards a metabolic anti-influenza therapy
Prof. Adrian Martineau - Vitamin D in the prevention and treatment of respiratory infections
Vitamin D is best known for its effects on calcium homeostasis, but a growing body of evidence shows that it also has extensive immunomodulatory actions. In this talk I will describe the effects of vitamin D metabolites on host responses to respiratory pathogens, before going on to review results of clinical trials that have evaluated a potential role for vitamin D in the prevention and treatment of acute respiratory infections and tuberculosis. The potential for vitamin D to reduce incidence and severity of COVID-19 will also be discussed.